Skye Bioscience to Present at H.C. Wainwright 25th Annual Global Investment Conference

1 year ago

San Diego, California--(Newsfile Corp. - September 5, 2023) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye"), a pharmaceutical company developing proprietary…

Blackrock Health Announces €25 Million Investment In New Digital Transformation Programme Creating 60 Jobs

1 year ago

The group has selected MEDITECH Expanse as its electronic health record system. Blackrock Health will also introduce Ireland’s first integrated…

MindBio Therapeutics Announces Major Genetic Discovery in Microdosing Research

1 year ago

Genetic Discovery: MindBio's genetic testing in clinical research yields novel discovery for targeted diagnosis and treatmentSignificant Intellectual Property & Know…

Defence’s Innovative Therapeutics Featured on Viewpoint with Dennis Quaid

1 year ago

Vancouver, British Columbia--(Newsfile Corp. - September 5, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence"…

Occlutech Q2 2023 – Continued strong revenue growth

1 year ago

SCHAFFHAUSEN, CH / ACCESSWIRE / September 05, 2023 / Occlutech Holding AG Occlutech Holding AG (Occlutech) is a leading specialist…

Angle PLC Announces ANGLE launch of Portrait Flex assay

1 year ago

LAUNCH OF PORTRAIT FLEX CIRCULATING TUMOR CELL ASSAYThe Portrait Flex assay provides tailored analyses performed as a service by ANGLE's…

Xenon Pharmaceuticals Showcases XEN1101 Epilepsy Program at 35th International Epilepsy Congress

1 year ago

New interim data from ongoing Phase 2b X-TOLE open-label extension demonstrates improvement in overall quality-of-life (QoL) when compared to baseline…

AQ Pharmaceuticals, Inc. Announces Results of JBA Brands GlucoTrojan (R) Study: Findings Show Reduction in Sugar Absorption

1 year ago

GARDEN GROVE, CA / ACCESSWIRE / September 3, 2023 / Affordable Quality Pharmaceuticals (AQP), established in 2000, has developed a…

Turnstone Biologics Corp. Reports Second Quarter 2023 Financial Results and Provides Business Update

1 year ago

Successfully closed upsized IPO, raising $88 million in gross proceeds to continue advancing pipeline of Selected TIL Therapy programsCash position…

Retirement of Chandra Panchal, PhD from the Board of Directors

1 year ago

TORONTO, Sept. 01, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a…